Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/8/2025

Management of Right Ventricular Conduction Delay

Introduction to Right Ventricular Conduction Delay

  • The American College of Cardiology recommends that the management of right ventricular conduction delay should focus on identifying underlying structural heart disease, assessing for progression to complete heart block, and considering physiologic pacing techniques when intervention is needed to prevent heart failure and improve mortality outcomes, particularly in patients with symptoms correlating with bradycardia, evidence of progression to higher-degree AV block, or alternating bundle branch block 1

Diagnosis and Risk Stratification

  • The presence of syncope or symptoms correlating with bradycardia is associated with a higher risk of cardiac events, and evidence of progression to higher-degree AV block is a significant concern 1
  • Alternating bundle branch block is a Class I indication for permanent pacing, according to the American College of Cardiology 1
  • Patients with left ventricular ejection fraction between 36-50% who are expected to require ventricular pacing >40% of the time should be considered for techniques that provide more physiologic ventricular activation, such as His bundle pacing, cardiac resynchronization therapy, or left bundle branch pacing, as recommended by the American College of Cardiology and the American Heart Association 1, 2
  • Diagnostic criteria for conduction disorders include:

    Conduction Disorder ECG Criteria
    Complete Right Bundle Branch Block (RBBB) QRS duration ≥120 ms, rsr', rsR', rSR', or rarely a qR pattern in leads V1 or V2, and an S wave of greater duration than R wave or >40 ms in leads I and V6 [1]
    Complete Left Bundle Branch Block (LBBB) QRS duration ≥120 ms, broad notched or slurred R wave in leads I, aVL, V5, and V6, absent Q waves in leads I, V5, and V6, and R peak time >60 ms in leads V5 and V6 [1]
    Left Anterior Fascicular Block (LAFB) QRS duration <120 ms, frontal plane axis between -45° and -90°, qR pattern in lead aVL, R-peak time in lead aVL of ≥45 ms, and rS pattern in leads II, III, and aVF [1, 3]
    Left Posterior Fascicular Block (LPFB) QRS duration <120 ms, frontal plane axis between 90° and 180°, rS pattern in leads I and aVL, and qR pattern in leads III and aVF [1, 3]
  • Nonspecific intraventricular conduction delay (NIVCD) is associated with a >3-fold increased risk of new-onset heart failure and may be associated with underlying structural heart disease, even when echocardiogram appears normal, according to the American College of Cardiology 1, 4
  • NIVCD carries a significantly higher risk of cardiac mortality and arrhythmic death compared to RBBB and LBBB, with QRS duration ≥140 ms being particularly concerning 1
  • In adults, a QRS duration >110 ms is considered a prolongation of the QRS complex duration beyond normal limits, indicating an intraventricular conduction delay (IVCD) 5
  • In children, the QRS duration considered prolonged varies by age:

Treatment and Management

  • Permanent pacing is recommended for acquired second-degree Mobitz type II, high-grade AV block, or third-degree AV block not caused by reversible causes, according to the American College of Cardiology (Class I recommendation) 1
  • For other types of AV block, permanent pacing should be considered only with symptoms that correlate with AV block, as recommended by the American College of Cardiology 1
  • Temporary transvenous pacing is reasonable in patients with persistent hemodynamically unstable bradycardia refractory to medical therapy, according to the American College of Cardiology (Class IIa, Level C-LD) 1
  • Temporary transcutaneous pacing may be considered in patients with severe symptoms or hemodynamic compromise, according to the American College of Cardiology (Class IIb, Level C-LD) 1
  • Temporary pacing should NOT be performed in patients with minimal/infrequent symptoms without hemodynamic compromise, according to the American College of Cardiology (Class III: Harm, Level C-LD) 1
  • Permanent pacing is recommended for patients with alternating bundle branch block, with a Class I, Level C-LD recommendation 3
  • Cardiac Resynchronization Therapy (CRT) should be considered for patients with heart failure, mildly to moderately reduced LVEF, and NIVCD with QRS ≥150 ms 1
  • Certain genetic and infiltrative disorders, such as lamin A/C mutations, sarcoidosis, and amyloidosis, with IVCD may warrant more aggressive management, with a recommendation based on expert opinion 3

Follow-up and Monitoring

  • Regular follow-up with periodic ECG monitoring is recommended as new conduction abnormalities may develop over time, and no specific therapy is indicated in the absence of symptoms or evidence of progression, according to the American College of Cardiology 1
  • Periodic reassessment of ventricular function, especially in patients with QRS duration ≥140 ms, is crucial for monitoring disease progression and guiding treatment decisions 1
  • The American College of Cardiology recommends ambulatory ECG monitoring for symptomatic patients where atrioventricular block is suspected, with a Class I recommendation (Level C-LD) 1
  • Advanced cardiac imaging, such as cardiac MRI, CT, or nuclear studies, should be considered if echocardiogram is normal but clinical suspicion for structural heart disease remains high, with a Class IIa recommendation (Level C-LD) 1
  • Electrophysiologic study (EPS) is reasonable in patients with symptoms suggestive of intermittent bradycardia with conduction system disease identified by ECG, with a Class IIa recommendation (Level B-NR) 1
  • Echocardiography is essential even in asymptomatic patients to exclude structural heart disease, with a Class IIa recommendation (Level B-NR) 1
  • The American College of Cardiology recommends considering ambulatory monitoring if bifascicular or trifascicular block is present 1
  • Patients with NIVCD and QRS duration ≥140 ms are at higher risk and may require more aggressive management 1
  • The American College of Cardiology recommends permanent pacing for patients with HV interval ≥70 ms or evidence of infranodal block at electrophysiologic study, with a Class I recommendation (Level C-LD) 1

REFERENCES